| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6826117 | Schizophrenia Research | 2013 | 6 Pages |
Abstract
In the present study, adjunctive therapy of intranasal insulin did not seem to improve body metabolism in patients with schizophrenia. The implications for future studies were discussed.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jie Li, Xue Li, Emily Liu, Paul Copeland, Oliver Freudenreich, Donald C. Goff, David C. Henderson, Xueqin Song, Xiaoduo Fan,